<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(3)</volume><submitter>EATRIS-Plus Multi-omics working group and Stakeholders</submitter><pubmed_abstract>Molecular characterization of a biological sample, e.g., with omics approaches, is fundamental for the development and implementation of personalized and precision medicine approaches. In this context, quality assessment is one of the most critical aspects. Accurate performance and interpretation of omics techniques is based on consensus, harmonization, and standardization of protocols, procedures, data analysis and reference values and materials. EATRIS, the European Infrastructure for Translational Medicine (www.EATRIS.eu), brings together resources and services to support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes. Here we describe the efforts within the Horizon 2020 EATRIS-Plus project and activitie</pubmed_abstract><journal>Phenomics (Cham, Switzerland)</journal><pagination>311-325</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12390891</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Multi-omics Quality Assessment in Personalized Medicine Through European Infrastructure for Translational Medicine (EATRIS): An Overview.</pubmed_title><pmcid>PMC12390891</pmcid><pubmed_authors>Shi L</pubmed_authors><pubmed_authors>Quintero I</pubmed_authors><pubmed_authors>Nieminen AI</pubmed_authors><pubmed_authors>Lindgren H</pubmed_authors><pubmed_authors>Nordlund J</pubmed_authors><pubmed_authors>Tunstall T</pubmed_authors><pubmed_authors>Nazir K</pubmed_authors><pubmed_authors>Valenti B</pubmed_authors><pubmed_authors>Weiss J</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Gloerich J</pubmed_authors><pubmed_authors>Maestro R</pubmed_authors><pubmed_authors>Overnas E</pubmed_authors><pubmed_authors>Donner K</pubmed_authors><pubmed_authors>Ghimire B</pubmed_authors><pubmed_authors>Ekberg S</pubmed_authors><pubmed_authors>Alonso-Andres P</pubmed_authors><pubmed_authors>Dzubak P</pubmed_authors><pubmed_authors>Martin T</pubmed_authors><pubmed_authors>Saracino S</pubmed_authors><pubmed_authors>Stankova J</pubmed_authors><pubmed_authors>Conde Moreno E</pubmed_authors><pubmed_authors>Baldazzi D</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Puhka M</pubmed_authors><pubmed_authors>Niehues A</pubmed_authors><pubmed_authors>Rodriguez-Serrano EM</pubmed_authors><pubmed_authors>Palva A</pubmed_authors><pubmed_authors>Crespo-Toro L</pubmed_authors><pubmed_authors>Scherer A</pubmed_authors><pubmed_authors>van Gool A</pubmed_authors><pubmed_authors>Yadav B</pubmed_authors><pubmed_authors>Garcia Bermejo ML</pubmed_authors><pubmed_authors>Najdekr L</pubmed_authors><pubmed_authors>Ramos-Munoz ME</pubmed_authors><pubmed_authors>Zizkovicova P</pubmed_authors><pubmed_authors>T Hoen PB</pubmed_authors><pubmed_authors>Hannula S</pubmed_authors><pubmed_authors>EATRIS-Plus Multi-omics working group and Stakeholders</pubmed_authors><pubmed_authors>Habier J</pubmed_authors><pubmed_authors>Gasparotto D</pubmed_authors><pubmed_authors>Oldoni E</pubmed_authors><pubmed_authors>Mattila P</pubmed_authors><pubmed_authors>Hajduch M</pubmed_authors><pubmed_authors>Halder R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Multi-omics Quality Assessment in Personalized Medicine Through European Infrastructure for Translational Medicine (EATRIS): An Overview.</name><description>Molecular characterization of a biological sample, e.g., with omics approaches, is fundamental for the development and implementation of personalized and precision medicine approaches. In this context, quality assessment is one of the most critical aspects. Accurate performance and interpretation of omics techniques is based on consensus, harmonization, and standardization of protocols, procedures, data analysis and reference values and materials. EATRIS, the European Infrastructure for Translational Medicine (www.EATRIS.eu), brings together resources and services to support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes. Here we describe the efforts within the Horizon 2020 EATRIS-Plus project and activitie</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-04-08T15:28:24.475Z</modification><creation>2026-04-08T04:45:13.341Z</creation></dates><accession>S-EPMC12390891</accession><cross_references><pubmed>40895321</pubmed><doi>10.1007/s43657-024-00170-0</doi></cross_references></HashMap>